Article Name Clinical Trials and Research
Robust clinical pipeline that spans multiple late-stage studies across intermediate- and high-risk NMIBC
08th December, 2025
FDA approval marks Alpha Tau’s fifth simultaneous active U.S. IDE as the Company expands Alpha DaRT’s reach into recurrent prostate cancer
03rd December, 2025
Integrated with the OrthoPulse App and Doctor Portal 2.0, OrthoPulse lite forms a connected, data-driven ecosystem
03rd December, 2025
The Company will collaborate with DK Healthcare to obtain the necessary regulatory clearances ahead of commercial launch in South Korea
25th November, 2025
Cerene is rapidly gaining traction among clinicians seeking predictable outcomes without the pain, scarring, or anaesthesia requirements associated with heat-based methods
24th November, 2025
Matrix NEO is the world's first automated single-cell analysis platform to achieve medical device clearance, marking a milestone in bringing single-cell sequencing from research laboratories into clinical practice
17th November, 2025
The clinical study was conducted at the Territorial Medical Association of Yangiyul district, Republic of Uzbekistan, and received Ethics Committee approval
13th November, 2025
Preat introduces its first proprietary overdenture attachment system to advance overdenture reliability through performance and partnership
12th November, 2025
The trial enrolled 65 participants undergoing routine skin biopsy, with cross-modal imaging performed before tissue collection
07th November, 2025
The asset acquisition gives Acumed full ownership of TECHFIT's proprietary technologies, including its digital surgical planning and reconstruction platform
06th November, 2025
Designed as a safe, accessible, and office-based alternative to surgical sterilization, FemBloc represents a paradigm shift in permanent contraception
05th November, 2025
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months
04th November, 2025
Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data
03rd November, 2025
The strategic partnership is set to fully unlock the patent value and productisation capabilities of CoolMPS, complementing MGI's tried-and-true StandardMPS technology
29th October, 2025
Expanded partnerships with leading European centres create a strategic pathway to accelerate market adoption and drive future commercialisation opportunities
15th October, 2025
EVM14, an off-the-shelf therapeutic mRNA cancer vaccine, was developed based on Everest Medicines' proprietary mRNA platform
15th October, 2025
Findings presented at the International VT Symposium and published simultaneously in Circulation
13th October, 2025
Nutromics’ Lab-on-a-Patch, a pioneering biosensing platform capable of simultaneously tracking multiple molecular targets through a single wearable device
10th October, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer